vs
Side-by-side financial comparison of ACME UNITED CORP (ACU) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
ACME UNITED CORP is the larger business by last-quarter revenue ($52.3M vs $38.3M, roughly 1.4× ImmunityBio, Inc.). ACME UNITED CORP runs the higher net margin — 1.9% vs -161.8%, a 163.7% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 13.8%).
Acme United Corporation is a supplier of cutting, measuring and safety products for the school, home, office, hardware and industrial markets. The company was organized as a partnership in 1867 and incorporated in 1873 under the laws of the State of Connecticut. It is publicly traded on the NYSE American with symbol ACU.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
ACU vs IBRX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $52.3M | $38.3M |
| Net Profit | $985.0K | $-61.9M |
| Gross Margin | 39.7% | 99.0% |
| Operating Margin | 3.3% | -169.0% |
| Net Margin | 1.9% | -161.8% |
| Revenue YoY | 13.8% | 407.0% |
| Net Profit YoY | -40.4% | -4.7% |
| EPS (diluted) | $0.24 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $52.3M | — | ||
| Q4 25 | $47.5M | $38.3M | ||
| Q3 25 | $49.1M | $32.1M | ||
| Q2 25 | $54.0M | $26.4M | ||
| Q1 25 | $46.0M | $16.5M | ||
| Q4 24 | $45.9M | $7.6M | ||
| Q3 24 | $48.2M | $6.1M | ||
| Q2 24 | $55.4M | — |
| Q1 26 | $985.0K | — | ||
| Q4 25 | $1.9M | $-61.9M | ||
| Q3 25 | $1.9M | $-67.3M | ||
| Q2 25 | $4.8M | $-92.6M | ||
| Q1 25 | $1.7M | $-129.6M | ||
| Q4 24 | $1.7M | $-59.2M | ||
| Q3 24 | $2.2M | $-85.7M | ||
| Q2 24 | $4.5M | — |
| Q1 26 | 39.7% | — | ||
| Q4 25 | 38.2% | 99.0% | ||
| Q3 25 | 39.1% | 99.4% | ||
| Q2 25 | 41.0% | 99.5% | ||
| Q1 25 | 39.0% | 99.6% | ||
| Q4 24 | 38.7% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 40.8% | — |
| Q1 26 | 3.3% | — | ||
| Q4 25 | 6.1% | -169.0% | ||
| Q3 25 | 6.1% | -173.5% | ||
| Q2 25 | 11.8% | -269.8% | ||
| Q1 25 | 5.3% | -390.1% | ||
| Q4 24 | 5.0% | -919.0% | ||
| Q3 24 | 6.1% | -1314.3% | ||
| Q2 24 | 11.5% | — |
| Q1 26 | 1.9% | — | ||
| Q4 25 | 3.9% | -161.8% | ||
| Q3 25 | 3.9% | -209.8% | ||
| Q2 25 | 8.8% | -350.3% | ||
| Q1 25 | 3.6% | -784.9% | ||
| Q4 24 | 3.7% | -783.4% | ||
| Q3 24 | 4.6% | -1404.0% | ||
| Q2 24 | 8.0% | — |
| Q1 26 | $0.24 | — | ||
| Q4 25 | $0.46 | $-0.06 | ||
| Q3 25 | $0.46 | $-0.07 | ||
| Q2 25 | $1.16 | $-0.10 | ||
| Q1 25 | $0.41 | $-0.15 | ||
| Q4 24 | $0.43 | $-0.08 | ||
| Q3 24 | $0.54 | $-0.14 | ||
| Q2 24 | $1.09 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.2M | $242.8M |
| Total DebtLower is stronger | $33.0M | — |
| Stockholders' EquityBook value | $116.7M | $-500.5M |
| Total Assets | $195.2M | $501.9M |
| Debt / EquityLower = less leverage | 0.28× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $4.2M | — | ||
| Q4 25 | $3.6M | $242.8M | ||
| Q3 25 | $5.1M | $257.8M | ||
| Q2 25 | $3.6M | $153.7M | ||
| Q1 25 | $3.4M | $61.6M | ||
| Q4 24 | $6.4M | $149.8M | ||
| Q3 24 | $5.7M | $130.4M | ||
| Q2 24 | $3.8M | — |
| Q1 26 | $33.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $116.7M | — | ||
| Q4 25 | $117.6M | $-500.5M | ||
| Q3 25 | $115.8M | $-524.3M | ||
| Q2 25 | $113.7M | $-570.7M | ||
| Q1 25 | $108.3M | $-591.4M | ||
| Q4 24 | $107.0M | $-489.1M | ||
| Q3 24 | $106.3M | $-745.1M | ||
| Q2 24 | $104.0M | — |
| Q1 26 | $195.2M | — | ||
| Q4 25 | $171.0M | $501.9M | ||
| Q3 25 | $173.0M | $519.0M | ||
| Q2 25 | $170.9M | $402.1M | ||
| Q1 25 | $163.0M | $303.8M | ||
| Q4 24 | $162.2M | $382.9M | ||
| Q3 24 | $165.5M | $364.6M | ||
| Q2 24 | $173.5M | — |
| Q1 26 | 0.28× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-70.4M |
| Free Cash FlowOCF − Capex | — | $-71.3M |
| FCF MarginFCF / Revenue | — | -186.2% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.2M | $-70.4M | ||
| Q3 25 | $7.1M | $-68.9M | ||
| Q2 25 | $6.3M | $-79.7M | ||
| Q1 25 | $-3.3M | $-85.9M | ||
| Q4 24 | $6.4M | $-85.1M | ||
| Q3 24 | $8.9M | $-98.8M | ||
| Q2 24 | $6.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | $7.3M | $-71.3M | ||
| Q3 25 | $301.0K | $-69.6M | ||
| Q2 25 | $4.7M | $-80.8M | ||
| Q1 25 | $-4.7M | $-87.0M | ||
| Q4 24 | $4.7M | $-87.3M | ||
| Q3 24 | $7.5M | $-101.6M | ||
| Q2 24 | $4.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | -186.2% | ||
| Q3 25 | 0.6% | -217.2% | ||
| Q2 25 | 8.7% | -305.9% | ||
| Q1 25 | -10.2% | -526.9% | ||
| Q4 24 | 10.2% | -1155.4% | ||
| Q3 24 | 15.6% | -1663.2% | ||
| Q2 24 | 8.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 2.4% | ||
| Q3 25 | 13.8% | 2.3% | ||
| Q2 25 | 3.0% | 4.1% | ||
| Q1 25 | 2.9% | 6.8% | ||
| Q4 24 | 3.7% | 28.0% | ||
| Q3 24 | 2.8% | 45.7% | ||
| Q2 24 | 4.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 4.34× | — | ||
| Q3 25 | 3.72× | — | ||
| Q2 25 | 1.33× | — | ||
| Q1 25 | -2.02× | — | ||
| Q4 24 | 3.73× | — | ||
| Q3 24 | 3.99× | — | ||
| Q2 24 | 1.55× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
